Similar Articles |
|
The Motley Fool October 4, 2006 Rick Aristotle Munarriz |
WCI Surprises No One The condo bubble casualty warns -- but it had to end this way. A lot of factors are coming into play here -- and none of them are encouraging. Investors, take note. |
The Motley Fool October 19, 2007 Rick Aristotle Munarriz |
Dueling Fools: Bearish on Homebuilders The bearish view of homebuilding stocks is that the situation can get much worse than it currently is, and it will. |
The Motley Fool September 8, 2006 Rick Aristotle Munarriz |
Say It Ain't So, St. Joe The Florida landowner bows out of the home-builder market. |
The Motley Fool February 26, 2007 Rick Aristotle Munarriz |
Can Florida Save Its Homebuilders? The Sunshine State has a plan to lift developer storm clouds. Will the Florida-heavy real estate companies benefit if the property tax measure passes? Investors, take note. |
The Motley Fool October 4, 2006 Brian Lawler |
Unwelcome Guests at ImClone ImClone's board of directors votes against Carl Icahn's proposed removal of six company directors. Short-term shareholders that are able to cash out with Icahn, will possibly have a nice gain to take home. |
The Motley Fool September 7, 2006 Rick Aristotle Munarriz |
KO at KB KB Home warns, but no one is surprised. Investors, eventually there will be a time to climb back in. So dig into due diligence now to find attractive players, but keep that hardhat on. |
The Motley Fool January 26, 2007 Rich Duprey |
Beazer's Cloudy Future The home-builder reports dismal earnings. Shocking. While Beazer hopes the spring quarter shows more robust results, it has lowered guidance for the full year to $1.25 to $1.50 per share. |
The Motley Fool September 6, 2007 Sham Gad |
Invest in Special Situations Value investors have more than one way to take advantage of bargains. They also have special situations securities, sometimes called "workouts," whose performance is not directly tied to any market environment. Can they work for you? |
The Motley Fool January 29, 2008 Brian Lawler |
Icahn Tries to Board USS Biogen Carl Icahn and the funds that he runs announce that they will try to get elected to three seats on the board of directors at Biogen Idec. |
The Motley Fool March 30, 2011 Anders Bylund |
Mentor Could Use Some Guidance Is the company looking to preserve shareholder interest or management paychecks? |
The Motley Fool October 25, 2006 Brian Lawler |
Earnings Soothe ImClone Investors For long-term shareholders of ImClone stock, it will be hard to bask in the glory of ImClone's positive earnings for long. Numerous looming issues surround the company, including the Yeda patent dispute, coming competition from Amgen's Vectibix, and possible shareholder shenanigans from Icahn. |
The Motley Fool July 8, 2008 Rick Aristotle Munarriz |
Doesn't Yahoo! Get a Say? Billionaire investor Carl Icahn and Microsoft insist that only a new boardroom -- ideally populated by the slate of directors that Icahn is proposing -- will lead Microsoft to reopen acquisition talks with Yahoo!. |
The Motley Fool May 29, 2008 Brian Lawler |
Icahn Girds for Biogen Battle The activist investor officially launches his bid to usurp Biogen's board of directors. |
BusinessWeek March 5, 2007 Ronald Grover |
Just Don't Call Him A Raider Carl Icahn, who now styles himself a shareholder activist, prepares for battle with Motorola. |
BusinessWeek March 6, 2006 Ronald Grover |
Carl Icahn: Still An Improbable Robin Hood Carl Icahn is out to recast himself as the hedge fund investor's champion. That image has its critics. |
The Motley Fool August 1, 2008 Brian Lawler |
Is $60 a Share Enough for ImClone? Bristol-Myers Squibb announced a $60-per-share offer for ImClone Systems, but are shareholders going to go for the deal? |
The Motley Fool February 8, 2005 Tom Taulli |
Retro Raider Strikes Again Carl Icahn has been very busy lately -- and his most recent prey is cardboard packaging manufacturer Temple-Inland. The stock closed unchanged yesterday at $75.75. It had surged 16% when his interest in the stock became public. |
The Motley Fool June 11, 2008 Brian Lawler |
He Said, Biogen Said Pharmaceutical Biogen Idec's battle with Carl Icahn is coming to a head. |
The Motley Fool April 15, 2005 Tom Taulli |
Carl Icahn Strikes Again Energy and inorganic-chemical company Kerr-McGee and investor Icahn make peace. The market's happy, and Icahn's war chest just gets bigger. |
The Motley Fool December 7, 2007 Rick Aristotle Munarriz |
Throw the Book at Book Value In short, there are both opportunities and pitfalls in relying too much on book value. |
The Motley Fool July 22, 2011 Evan Niu |
Clorox to Icahn: "It's Not You, It's Me" Clorox announces that its board has unanimously rejected Icahn's unsolicited bid to acquire the company. |
The Motley Fool January 16, 2007 Rick Aristotle Munarriz |
Tomb, Sweet Tomb Publicly traded homebuilders are the sector's strongest players, yet they continue to show steeper drops in new home orders than deliveries. Speculators are simply trying their luck at catching falling knives. |
The Motley Fool May 15, 2008 Rick Aristotle Munarriz |
Bored of Directors at Yahoo! Carl Icahn has Yahoo!'s board in his crosshairs. |
The Motley Fool February 23, 2010 Brian Orelli |
Icahn Puts His Proxy Fight Where His Money Is How patient will Carl Icahn be with Genzyme's turnaround plan? That's the $270 million question -- the value of Icahn's shares, based on his holdings at the end of the year. |
The Motley Fool April 30, 2007 Tom Taulli |
Proxy Fights 101 How shareholder skirmishes are transforming Wall Street. It's smart to understand how proxy fights work, but don't assume they're a good system for investing. Proxy battles often target struggling companies with volatile stocks. |
The Motley Fool November 30, 2005 Rick Aristotle Munarriz |
I Think Icahn, Time Warner Despite the market's interest in Time Warner's online operations, billionaire investor Carl Icahn still believes that more can be done to improve shareholder value. |
InternetNews March 24, 2008 |
Icahn Sues Motorola to Get Access to Documents Investor Carl Icahn said on Monday he is suing Motorola to force it to hand over documents related to its mobile devices business, and he urged investors to elect his slate of candidates to the Motorola board. |
The Motley Fool October 12, 2005 W.D. Crotty |
Icahn's Case for Time Warner Carl Icahn issues an open letter to shareholders pushing for change on the company's board. Investors should realize, though, that just because Icahn is around, that doesn't mean their shares will automatically go up. |
The Motley Fool December 9, 2005 Stephen D. Simpson |
Toll Gets Wrung Slowing new home demand could squeeze margins and seems certain to slow the pace of earnings growth. |
The Motley Fool December 18, 2009 Rick Aristotle Munarriz |
Grand Theft Icahn The activist-investor is taking an 11% stake in the struggling video-game company Take-Two Interactive. |
The Motley Fool September 21, 2006 Brian Lawler |
ImClone's Board Shakeup A new face in the boardroom heralds change for the troubled company. Shareholders yesterday elected notorious corporate raider Carl Icahn to the company's board of directors. |
The Motley Fool February 17, 2006 Rick Aristotle Munarriz |
A Time for Peace Carl Icahn appears to have come to a truce with Time Warner over his breakup plans. However, a significant show of shareholders siding with Icahn's nominees may also force Time Warner to take a harder look at why it can't seem to get its stock out of the high teens. |
The Motley Fool November 23, 2004 Charly Travers |
Mylan's "Three-Ring Circus" Carl Icahn is involved in the Mylan-King Pharmaceuticals so he can manipulate this situation to make money. And a lot of it. |
The Motley Fool May 24, 2006 Stephen D. Simpson |
Has Toll Gotten Wrung Out? Sure times are tougher in the homebuilding segment, but this may offer investors an opportunity to buy. Remember, there's a time for prudent skepticism and a time for blatant opportunism. |
The Motley Fool September 1, 2009 Rick Aristotle Munarriz |
Icahn Handles the Truth at Yahoo! Carl Icahn has sold shares of struggling online giant Yahoo! in each of the past three trading days, enough to take his stake below 5%. |
The Motley Fool September 29, 2011 Evan Niu |
Does HP Need a Poison Pill? HP may have tapped Goldman Sachs to defend itself against activist investors. |
InternetNews March 24, 2008 Judy Mottl |
Icahn Challenges Motorola on Handheld Strategy Motorola stockholder and longtime critic Carl Icahn is seeking answers about the company's floundering performance, filing a lawsuit today seeking documents related to Moto's beleaguered mobile device division. |
The Motley Fool October 14, 2011 Travis Hoium |
Navistar International Shares Popped: What You Need to Know Shares of Navistar International drove as much as 16% higher today before dropping to a more modest gain of 8% mid-day. |
The Motley Fool September 18, 2007 Tom Taulli |
Icahn Beats Up BEA Why has the legendary corporate activist set his sights on the struggling software developer? Investors, take note. |
The Motley Fool February 28, 2007 David Lee Smith |
Florida Flags Hovnanian The homebuilder takes $90 million in charges in the Sunshine State. The housing market continues to exhibit softness nationwide, with some areas clearly being harder hit than others. Investors, take note. |
The Motley Fool February 4, 2010 Stephen Mauzy |
My Favorite Investor I think that for most investors, the Icahn approach of buying distressed companies at very good prices even surpasses the Warren Buffett approach of buying good companies at fair prices. |
The Motley Fool March 15, 2008 Rick Aristotle Munarriz |
The Fool's Look Ahead Who's reporting this week: WCI Communities... Gamestop... China Mobile... Nepstar... FedEx... WorldSpace... |
The Motley Fool March 23, 2010 Brian Orelli |
Icahn and Biogen Kiss and Make Up He gets one more seat on the board, so what's next? |
The Motley Fool August 5, 2008 Brian Lawler |
An ImClone Deal Will Get Done Despite his tough talk, Icahn will likely complete a buyout of ImClone. |
The Motley Fool January 30, 2009 Brian Orelli |
Icahn's Next Target Activist investor Carl Icahn has decided to nominate a slate of five directors for the board of Amylin Pharmaceuticals, of which he owns 8.3%. |
The Motley Fool June 10, 2010 Brian Orelli |
Cancel the Clowns: Icahn Avoids a Circus The billionaire investor backs down from a fight. He withdrew his slate of candidates to join Genzyme's board yesterday. |
The Motley Fool April 16, 2009 Brian Orelli |
Icahn: Ludicrous and Arrogant Fun to read, but does he have the best intentions for long-term shareholders? |
National Real Estate Investor December 4, 2002 Parke Chapman |
Investor now holds 6.9% stake in Insignia Carl Icahn now holds a 6.9% stake in real estate operator Insignia Financial Group Inc. |
InternetNews January 16, 2008 |
Oracle Prevails in BEA Bid Oracle won a three-month-long campaign to buy BEA Systems by raising its bid for the business software maker by 14 percent to $8.5 billion. |
The Motley Fool February 8, 2006 Rick Aristotle Munarriz |
Time Warner's Splitting Headache Carl Icahn's investment banker suggests Time Warner break up into four pieces. But the company is doing its part to make investors know that it's not asleep at the wheel. With every quarterly improvement, Icahn's voice is likely to grow that much quieter. |